Inmed Pharmaceuticals Inc. · NASDAQ:INM
ADAR1 Capital Management, LLC bought 1,087 Inmed Pharmaceuticals Inc. shares (Form 4)
Traded Oct 16 to Oct 19, 2026 · Filed Oct 20, 2026
From Oct 16 to Oct 19, 2026, ADAR1 Capital Management, LLC (10% owner) bought 1,087 Inmed Pharmaceuticals Inc. shares at US$1.32 for US$1,435, leaving 956,580 shares. Filed Oct 20, 2026 (Form 4).
- Bought
- 1,087 shares
- Price
- US$1.32
- Value
- US$1,435
- Holding after
- 956,580 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Common Shares | Buy | 1 | US$1.32 | 955,494 | Indirect |
| Oct 19, 2026 | Common Shares | Buy | 1,086 | US$1.32 | 956,580 | Indirect |
Source
Download original · View original at SEC
Related
- Inmed Pharmaceuticals Inc.
- ADAR1 Capital Management, LLC
- Inmed Pharmaceuticals Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Oct 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 8, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 5, 2026
- Form 4 · ADAR1 Capital Management, LLC · Jul 17, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Oct 7, 2026
- Form 4 · Schneeberger Daniel · Sep 16, 2026
- Schedule 13G · Ikarian Capital, LLC · Aug 14, 2026
- Form 4 · Vivo Opportunity Cayman Fund, L.P. · Jul 16, 2026
- Form 4 · Vivo Opportunity, LLC · Jul 2, 2026